Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Statera BioPharma Cash from Investing (Quarterly): 0.00 for Sept. 30, 2022
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.0065M |
| December 31, 2021 | -0.0969M |
| Date | Value |
|---|---|
| September 30, 2021 | 13.04M |
| June 30, 2021 | 0.5196M |
| March 31, 2021 | -0.0047M |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.0969M
Minimum
Dec 2021
13.04M
Maximum
Sep 2021
1.682M
Average
--
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Humanigen Inc | -- |
| Cantabio Pharmaceuticals Inc | -- |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | -0.959M |
| Scopus BioPharma Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.8015M |
| Cash from Financing (Quarterly) | 0.7117M |